Cadrenal Therapeutics (CVKD) Selling, General & Administrative (2022 - 2026)
Cadrenal Therapeutics (CVKD) recorded Selling, General & Administrative of $2.63 million in Q2 2026, down 0.8% from $2.66 million a year earlier.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Selling, General & Administrative (2022 - 2026) Analysis & Trends
On a TTM basis, Cadrenal Therapeutics' Selling, General & Administrative came in at $8.18 million as of Jun 30, 2026, up 22.6% year-over-year; for FY2023, it was $3.55 million, up 53.8% from FY2022.
- Across earlier years, Selling, General & Administrative came in at $2.31 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q3 2024.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 531.9% in Q1 2023, against a decline of 5.9% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Cadrenal Therapeutics | 557,746.58 | -12.06 Mn | - | 2.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.63 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 2.25 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 902,107.00 |
| Sep 30, 2023 | 898,051.00 |
| Jun 30, 2023 | 784,623.00 |
| Mar 31, 2023 | 964,732.00 |
| Dec 31, 2022 | 958,833.00 |
| Sep 30, 2022 | 915,897.00 |
| Jun 30, 2022 | 280,112.00 |
| Mar 31, 2022 | 152,661.00 |
API Access
Cadrenal Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CVKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();